ReviewCells2023
Insight and Recommendations for Fragile X-Premutation-Associated Conditions from the Fifth International Conference on
Open access · goldAbstract readReview
In one paragraph
Review in Cells, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.
0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
18.5field-weighted citation impact, top 1% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
48 citing papers in PubMed, 59 citations in OpenAlex.
- Fragile X-associated tremor/ataxia syndrome with autoimmune hepatitis requiring liver transplantation.BMJ case reports · 2026Article
- Autonomic Nervous System Function and Sensory Sensitivity in 12-Month-Old Infants with theInternational journal of molecular sciences · 2026Article
- Use of Machine Learning to Identify Markers of Risk for Fragile X-Associated Tremor/Ataxia Syndrome: A Preliminary Analysis.Annals of neurology · 2026Article
- Large-scale analysis of FMR1 CGG repeat length and risk of premature ovarian insufficiency in over 92 000 women.Human reproduction (Oxford, England) · 2026Article
- Planning for the Transition to Adulthood: Parent Perspectives on the Planning Process and Experiences of Young Adults with Fragile X Syndrome.Advances in neurodevelopmental disorders · 2026Article
- The apolipoprotein gene: a modulating role on brain volume and cognitive function in carriers of the fragile X premutation.Neurobiology of disease · 2026Article
- An Out-of-Place Etiology: Recognizing FMR1 Premutation in the Memory Clinic.Annals of clinical and translational neurology · 2026Article
- Clinical Heterogeneity in a Scandinavian FMR1 Premutation Carrier Cohort and Basal Ganglia Atrophy in FXTAS.Cerebellum (London, England) · 2026Article
- T2-FLAIR hyperintensities in the inferior cerebellar peduncles and their association with clinical symptoms, molecular and MRI markers in maleFrontiers in molecular neuroscience · 2026Article
- Improving women's healthcare providers' knowledge about fragile X-associated primary ovarian insufficiency through a novel educational tool.Journal of assisted reproduction and genetics · 2026Article
- Progression of fragile X-associated tremor/ataxia syndrome revealed by subtype and stage inference.Brain communications · 2026Article
- Glymphatic dysfunction and neuroinflammation in FXTAS: evidence from DTI-ALPS and gene expression analysis.Frontiers in molecular neuroscience · 2026Article
- Integrated multi-omics profiling reveals novel molecular biomarkers and pathways associated with Fragile X-associated tremor/ataxia syndrome.Frontiers in molecular neuroscience · 2026Article
- Chronic pain, fatigue, and emotional distress in femaleFrontiers in molecular neuroscience · 2026Article
- Optimizing single-session CBT delivery in an 8-session longitudinal therapeutic assessment (FRAX-TA) for women withFrontiers in molecular neuroscience · 2026Article
- Use of the Behavioral Dyscontrol Scale-2 (BDS-2) to measure executive dysfunction in FXTAS.Frontiers in molecular neuroscience · 2026Article
- IGF2BPs directly regulate the noncanonical translation of toxic proteins from mutant FMR1 mRNA containing expanded CGG repeats.Nature communications · 2025Article
- Parallel paths: A narrative review exploring autism and its co-occurring conditions.World journal of clinical pediatrics · 2025Review
- Swallowing and choking difficulties as potential markers of FXTAS progression in FMR1 premutation carriers.Scientific reports · 2025Article
- Longitudinal Analysis of Neuroradiological Biomarkers for Fragile X-Associated Tremor/Ataxia Syndrome and Implications for Clinical Trials.Annals of neurology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
46 authors at 20 institutions in 9 countries.
Flora TassoneDepartment of Biochemistry and Molecular Medicine, School of Medicine, University of California Davis, Sacramento, CA 95817, USA.ORCID 0000-0002-6388-9180
Dragana ProticDepartment of Pharmacology, Clinical Pharmacology and Toxicology, Faculty of Medicine, University of Belgrade, 11129 Belgrade, Serbia.ORCID 0000-0002-2137-5405
Emily Graves AllenDepartment of Human Genetics, Emory University School of Medicine, Atlanta, GA 30322, USA.
Alison D ArchibaldVictorian Clinical Genetics Services, Royal Children's Hospital, Melbourne, VIC 3052, Australia.ORCID 0000-0002-4496-8262
Anna BaudDepartment of Gene Expression, Institute of Molecular Biology and Biotechnology, Adam Mickiewicz University, Uniwersytetu Poznańskiego 6, 61-614 Poznan, Poland.
Ted W BrownCentral Clinical School, University of Sydney, Sydney, NSW 2006, Australia.
Dejan B BudimirovicDepartment of Psychiatry, Fragile X Clinic, Kennedy Krieger Institute, Baltimore, MD 21205, USA.ORCID 0000-0001-7263-5134
Jonathan CohenFragile X Alliance Clinic, Melbourne, VIC 3161, Australia.ORCID 0000-0002-9998-4681
Brett DufourMIND Institute, University of California Davis, Davis, CA 95817, USA.
Rachel EigesStem Cell Research Laboratory, Medical Genetics Institute, Shaare Zedek Medical Center Affiliated with the Hebrew University School of Medicine, Jerusalem 91031, Israel.
Nicola ElvassoreVeneto Institute of Molecular Medicine (VIMM), 35129 Padova, Italy.
Lidia V GabisKeshet Autism Center Maccabi Wolfson, Holon 5822012, Israel.ORCID 0000-0002-1612-5487
Samantha J GrudzienDepartment of Neurology, University of Michigan, 4148 BSRB, 109 Zina Pitcher Place, Ann Arbor, MI 48109, USA.
Deborah A HallDepartment of Neurological Sciences, Rush University, Chicago, IL 60612, USA.
David HesslMIND Institute, University of California Davis, Davis, CA 95817, USA.ORCID 0000-0002-3460-9805
Abigail HoganDepartment of Communication Sciences and Disorders, Arnold School of Public Health, University of South Carolina, Columbia, SC 29208, USA.
Jessica Ezzell HunterRTI International, Research Triangle Park, NC 27709, USA.
Peng JinDepartment of Human Genetics, Emory University School of Medicine, Atlanta, GA 30322, USA.ORCID 0000-0001-6137-6659
Poonnada JiraanontFaculty of Medicine, King Mongkut's Institute of Technology Ladkrabang, Bangkok 10520, Thailand.
Jessica KlusekDepartment of Communication Sciences and Disorders, Arnold School of Public Health, University of South Carolina, Columbia, SC 29208, USA.ORCID 0000-0002-2818-0344
R Frank KooyDepartment of Medical Genetics, University of Antwerp, 2000 Antwerp, Belgium.ORCID 0000-0003-2024-0485
Claudine M KraanDepartment of Paediatrics, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Melbourne, VIC 3052, Australia.ORCID 0000-0003-1805-6339
Cecilia LaterzaVeneto Institute of Molecular Medicine (VIMM), 35129 Padova, Italy.ORCID 0000-0002-3964-3375
Andrea LeeFragile X New Zealand, Nelson 7040, New Zealand.
Karen LipworthFragile X Association of Australia, Brookvale, NSW 2100, Australia.
Molly LoshRoxelyn and Richard Pepper Department of Communication Sciences and Disorders, Northwestern University, Evanston, IL 60201, USA.
Danuta LoeschSchool of Psychology and Public Health, La Trobe University, Melbourne, VIC 3086, Australia.ORCID 0000-0002-2180-2606
Reymundo LozanoDepartments of Genetics and Genomic Sciences and Pediatrics, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.ORCID 0000-0002-5616-5854
Marsha R MailickWaisman Center, University of Wisconsin-Madison, Madison, WI 53705, USA.
Apostolos ManolopoulosIntramural Research Program, Laboratory of Clinical Investigation, National Institute on Aging, Baltimore, MD 21224, USA.ORCID 0000-0003-1055-0324
Veronica Martinez-CerdenoMIND Institute, University of California Davis, Davis, CA 95817, USA.
Yingratana McLennanDepartment of Pathology and Laboratory Medicine, Institute for Pediatric Regenerative Medicine, Shriners Hospitals for Children of Northern California, School of Medicine, University of California Davis, Sacramento, CA 95817, USA.
Robert M MillerNational Fragile X Foundation, Washington, DC 20005, USA.
Federica Alice Maria MontanaroChild and Adolescent Neuropsychiatry Unit, Department of Neuroscience, Bambino Gesù Children's Hospital, IRCCS, 00165 Rome, Italy.ORCID 0000-0001-7293-2315
Matthew W MosconiSchiefelbusch Institute for Life Span Studies, University of Kansas, Lawrence, KS 66045, USA.
Sarah Nelson PotterRTI International, Research Triangle Park, NC 27709, USA.ORCID 0000-0002-8640-8992
Melissa RaspaRTI International, Research Triangle Park, NC 27709, USA.ORCID 0000-0003-3791-3367
Susan M RiveraDepartment of Psychology, University of Maryland, College Park, MD 20742, USA.
Katharine ShellyDepartment of Human Genetics, Emory University School of Medicine, Atlanta, GA 30322, USA.
Peter K ToddDepartment of Neurology, University of Michigan, 4148 BSRB, 109 Zina Pitcher Place, Ann Arbor, MI 48109, USA.ORCID 0000-0003-4781-6376
Katarzyna TutakDepartment of Gene Expression, Institute of Molecular Biology and Biotechnology, Adam Mickiewicz University, Uniwersytetu Poznańskiego 6, 61-614 Poznan, Poland.ORCID 0000-0002-2801-9956
Jun Yi WangCenter for Mind and Brain, University of California Davis, Davis, CA 95618, USA.
Anne WheelerRTI International, Research Triangle Park, NC 27709, USA.
Tri Indah WinarniCenter for Biomedical Research (CEBIOR), Faculty of Medicine, Universitas Diponegoro, Semarang 502754, Central Java, Indonesia.
Marwa ZafarullahDepartment of Biochemistry and Molecular Medicine, School of Medicine, University of California Davis, Sacramento, CA 95817, USA.ORCID 0000-0003-1856-0535
Randi J HagermanMIND Institute, University of California Davis, Davis, CA 95817, USA.ORCID 0000-0001-5029-8448
University of California, Davis · USRTI International · USEmory University · USShriners Hospitals for Children - Erie · USAdam Mickiewicz University in Poznań · PLUniversity of Michigan · USUniversity of Padua · ITUniversity of South Carolina · USBambino Gesù Children's Hospital · ITDiponegoro University · IDIcahn School of Medicine at Mount Sinai · USKennedy Krieger Institute · USKing Mongkut's Institute of Technology Ladkrabang · THLa Trobe University · AUNational Fragile X Foundation · USNational Institute on Aging · USNorthwestern University · USRoyal Children's Hospital · AURush University · USShaare Zedek Medical Center · IL
Funding
CGG repeat associated translation in Fragile X-associated Tremor/Ataxia Syndrome-Diversity SupplementR01NS086810 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI TODD, PETER K · 2014 to 2024
$4.1MFXTAS Key Molecular Pathways Converge with Other Neurodegenerative DisordersK01NS126736 · NINDS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Reymundo Lozano · 2022 to 2026
$1.4MAbstract
The premutation of the fragile X messenger ribonucleoprotein 1 (
Indexed as
Fragile X Messenger Ribonucleoprotein 1Fragile X SyndromeAtaxiaHumansMutationRNA, MessengerTremorTrinucleotide Repeat ExpansionFMR1 protein, humanFragile X Messenger Ribonucleoprotein 1RNA, MessengerFMR1 molecular and clinicalFMR1 premutationFXANDFXPACFXPOIFXTAS
Identifiers
What Socratic holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.